Bluejay Diagnostics Inc (BJDX)

$1.95 +0.06 (3.17%)
Market Cap 1.90M
Revenue (ttm) 0.00
Net Income (ttm) -6.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 10,000
Avg Vol 270,253
Day's Range N/A - N/A
Shares Out 972,000.00
Stochastic %K 65%
Beta 0.67
Analysts Strong Buy
Price Target $32.00

Company Profile

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests fo...

Industry: Medical Devices
Sector: Healthcare
Phone: 844 327 7078
Address:
360 Massachusetts Avenue, Suite 203, Acton, United States
Jj1369
Jj1369 Mar. 31 at 5:21 PM
$BJDX trash scam co going to zero!
0 · Reply
Jj1369
Jj1369 Mar. 30 at 8:43 PM
$BJDX lowest closing price of all time on the daily! QUITE LITERALLY A SCAM! Offering will send this to pennyland in a blink!
0 · Reply
Jj1369
Jj1369 Mar. 30 at 8:02 PM
$BJDX next time this scam sees $2.00 will be after the next RS
0 · Reply
Jj1369
Jj1369 Mar. 30 at 7:51 PM
$BJDX 1.50s tomorrow
0 · Reply
Jj1369
Jj1369 Mar. 30 at 7:48 PM
$BJDX new all time lows
0 · Reply
Jj1369
Jj1369 Mar. 30 at 7:46 PM
$BJDX hopeless scam Cash broke No rev Years from a viable product Toxic warrants Reverse split
0 · Reply
Combat_Vet
Combat_Vet Mar. 30 at 7:09 PM
$BJDX
1 · Reply
Jj1369
Jj1369 Mar. 30 at 6:01 PM
$BJDX insiders probably shorting their own trash stock
0 · Reply
Jj1369
Jj1369 Mar. 30 at 5:34 PM
$BJDX will never see $2.00 again hahahaha Endless downward spiral of a scam company!
0 · Reply
Jj1369
Jj1369 Mar. 30 at 4:32 PM
$BJDX toxic warrants inbound! Company is a scam! CEO should be in prison.
0 · Reply
Latest News on BJDX
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Mar 12, 2026, 6:30 AM EDT - 24 days ago

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics

Mar 11, 2026, 9:29 AM EDT - 25 days ago

NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics

Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised

Feb 20, 2026, 6:30 AM EST - 6 weeks ago

Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised

Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026

Feb 17, 2026, 6:30 AM EST - 6 weeks ago

Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

Dec 29, 2025, 7:00 AM EST - 3 months ago

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Oct 10, 2025, 5:16 PM EDT - 6 months ago

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Oct 9, 2025, 3:15 PM EDT - 6 months ago

Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

Oct 9, 2025, 6:30 AM EDT - 6 months ago

Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Aug 7, 2025, 6:30 PM EDT - 8 months ago

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Jun 3, 2025, 4:05 PM EDT - 10 months ago

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Apr 15, 2025, 7:00 AM EDT - 1 year ago

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Apr 7, 2025, 5:21 PM EDT - 1 year ago

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Bluejay Diagnostics Announces Reverse Stock Split

Nov 13, 2024, 5:10 PM EST - 1 year ago

Bluejay Diagnostics Announces Reverse Stock Split

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Jun 28, 2024, 11:32 AM EDT - 1 year ago

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Jun 26, 2024, 8:00 AM EDT - 1 year ago

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Jan 2, 2024, 5:58 PM EST - 2 years ago

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Dec 28, 2023, 8:00 AM EST - 2 years ago

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Dec 27, 2023, 9:00 AM EST - 2 years ago

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 4:05 PM EST - 2 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aug 25, 2023, 8:00 AM EDT - 2 years ago

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Aug 16, 2023, 7:00 AM EDT - 2 years ago

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

May 19, 2023, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

May 10, 2023, 7:30 AM EDT - 3 years ago

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

Bluejay Diagnostics Reports 2022 Financial Results

Mar 20, 2023, 4:15 PM EDT - 3 years ago

Bluejay Diagnostics Reports 2022 Financial Results

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Feb 16, 2023, 8:00 AM EST - 3 years ago

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Nov 9, 2022, 8:00 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

Sep 8, 2022, 9:33 AM EDT - 3 years ago

Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

STSS

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Aug 30, 2022, 4:05 PM EDT - 3 years ago

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Aug 16, 2022, 7:30 AM EDT - 3 years ago

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Jul 27, 2022, 7:30 AM EDT - 4 years ago

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Jul 26, 2022, 4:30 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Jul 6, 2022, 7:30 AM EDT - 4 years ago

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Why Bluejay Diagnostics Shares Are Surging Higher Today

Jun 9, 2022, 10:19 AM EDT - 4 years ago

Why Bluejay Diagnostics Shares Are Surging Higher Today

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Apr 20, 2022, 4:10 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Mar 28, 2022, 7:00 AM EDT - 4 years ago

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Mar 24, 2022, 7:00 AM EDT - 4 years ago

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Mar 10, 2022, 7:00 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Jan 31, 2022, 7:00 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Jan 13, 2022, 11:29 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Jan 5, 2022, 8:15 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Dec 16, 2021, 9:11 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

Nov 10, 2021, 8:15 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

Jj1369
Jj1369 Mar. 31 at 5:21 PM
$BJDX trash scam co going to zero!
0 · Reply
Jj1369
Jj1369 Mar. 30 at 8:43 PM
$BJDX lowest closing price of all time on the daily! QUITE LITERALLY A SCAM! Offering will send this to pennyland in a blink!
0 · Reply
Jj1369
Jj1369 Mar. 30 at 8:02 PM
$BJDX next time this scam sees $2.00 will be after the next RS
0 · Reply
Jj1369
Jj1369 Mar. 30 at 7:51 PM
$BJDX 1.50s tomorrow
0 · Reply
Jj1369
Jj1369 Mar. 30 at 7:48 PM
$BJDX new all time lows
0 · Reply
Jj1369
Jj1369 Mar. 30 at 7:46 PM
$BJDX hopeless scam Cash broke No rev Years from a viable product Toxic warrants Reverse split
0 · Reply
Combat_Vet
Combat_Vet Mar. 30 at 7:09 PM
$BJDX
1 · Reply
Jj1369
Jj1369 Mar. 30 at 6:01 PM
$BJDX insiders probably shorting their own trash stock
0 · Reply
Jj1369
Jj1369 Mar. 30 at 5:34 PM
$BJDX will never see $2.00 again hahahaha Endless downward spiral of a scam company!
0 · Reply
Jj1369
Jj1369 Mar. 30 at 4:32 PM
$BJDX toxic warrants inbound! Company is a scam! CEO should be in prison.
0 · Reply
Jj1369
Jj1369 Mar. 30 at 4:14 PM
$BJDX insiders bought $125K worth of shares to try snd pump this trash lol They’re down 15% already lol
0 · Reply
Jj1369
Jj1369 Mar. 30 at 3:32 PM
$BJDX
0 · Reply
Jj1369
Jj1369 Mar. 30 at 3:01 PM
$BJDX scam stock going to pennyland ! Short it to $.30
0 · Reply
MoneyMindsets
MoneyMindsets Mar. 29 at 5:03 AM
$BJDX Despite the recent small placement, $BJDX is burning through cash quickly (net loss of ~$6.8M in 2025). Investors should expect further dilution as the company seeks that additional $20M in funding
0 · Reply
TradeWithCreed
TradeWithCreed Mar. 27 at 8:19 PM
$AIB $BJDX $REI $BANL news?
0 · Reply
Jj1369
Jj1369 Mar. 27 at 6:28 PM
$BJDX monthly , weekly, daily, 4H It all looks like a disaster !!
0 · Reply
DarkSonar
DarkSonar Mar. 27 at 2:53 AM
$BJDX Nothing happens to this stock’s price!! Been waiting it for almost four months so I can buy some but the lack of life isn’t inspiring me to buy any shares 😅
1 · Reply
StockDocOne
StockDocOne Mar. 27 at 2:15 AM
$BJDX $EEIQ $UGRO
0 · Reply
Jj1369
Jj1369 Mar. 26 at 3:53 PM
$BJDX pump and dump scam trash Offering coming soon!
0 · Reply
OatesTheGoat
OatesTheGoat Mar. 26 at 3:01 PM
$BJDX 918k float and breaking over 2 hour 200 EMA which has previously been resistance. Over 2.33 this has a ton of upside
1 · Reply
Day3
Day3 Mar. 26 at 2:59 PM
$BJDX Similar float, share structure, price & range as $EEIQ & $UGRO before their huge moves. Most importantly as with the above, ZERO dilution on file. Added kicker is they are exploring the possibility of an acquisition+financing with a new 5% shareholder (all in the SEC filings). Theme developing here and BlueJay could be a top sympathy candidate. @6k_investor @STOCKSGambino
0 · Reply
Jj1369
Jj1369 Mar. 23 at 1:42 PM
$BJDX could not be more bearish! Scam is going to pennyland again!!
0 · Reply